Rnai molecule for treating cancer
AssigneeNitto Denko Corporation
InventorsHiroyuki TANAKA, Kenjiro MINOMI, Hirokazu TAKAHASHI, Yasuaki TAMURA, Norio TAKEI, Akihiro YONEDA
Life of this patent
Estimating the term…
Abstract
An RNAi molecule for cancer treatment, including the nucleotide sequence of SEQ ID NO: 1 in an antisense strand; and a method for treating a cancer, including administering an effective amount of the RNAi molecule to a subject in need thereof. The antisense strand includes the nucleotide sequence selected from SEQ ID NOs: 11-30.
Claims18
An RNAi molecule, comprising the nucleotide sequence of SEQ ID NO:
- 10 in an antisense strand.
(canceled)
(canceled)
A method for treating a disease caused by the expression of BcL-XL, comprising administering an effective amount of an RNAi molecule to a subject in need thereof, wherein the RNAi molecule comprises the nucleotide sequence of SEQ ID NO:
- 10 in an antisense strand, and wherein the RNAi molecule suppresses the protein expression of BcL-XL.
Dependencies are inferred from the claim text.